ARANA THERAPEUTICS LIMITED

AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer
Tue, 18 Mar 2008 03:00PM

Loading presentation... If nothing happens, you may need to install Flash and/or enable javascript in your browser.

Send a Message to Presenter

↓   ↓

↓   ↓
Message currently sending ... Sending ...

Send a link for this presentation to a friend

↓   ↓

↓   ↓
↓   ↓

↓   ↓
Message currently sending ...
Loading audio... If nothing happens please either:

Click to listen to audio on your default player or

Download the latest version of the Flash Player

Dr John Chiplin and Dr David Fuller

Tue, 18 Mar 2008
03:00PM Australia/NSW

Boardroom Radio Presented by